Enanta Pharmaceuticals, Inc. ENTA
NASDAQ · United States · Health Technology
$12.96+0.12 (+0.93%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 2026-08-10 | -0.67 | -0.51 | -31.5% | $14.36M | -14.3% | -1.8%$13.77→$13.52 |
| Q1 2026 | 2026-05-11 | -0.45 | -0.46 | +2.2% | — | — | -5.3%$15.34→$14.53 |
| Q1 2026 | 2026-02-09 | -0.42 | -0.80 | +47.5% | — | — | +4.6%$13.51→$14.13 |
| Q4 2025 | 2025-11-17 | -0.87 | -1.01 | +13.9% | — | — | +2.5%$12.06→$12.36 |
| Q3 2025 | 2025-08-11 | -0.85 | -0.88 | +3.4% | — | — | — |
| Q1 2025 | 2025-02-10 | -1.05 | -1.35 | +22.2% | — | — | — |
| Q4 2024 | 2024-11-25 | -1.36 | -0.92 | -47.8% | — | — | — |
| Q3 2024 | 2024-08-05 | -1.07 | -1.41 | +24.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.